Apyx Medical falls on FDA warning on use of device for aesthetic procedures

Apyx Medical

14/03/2022 15:38

** Shares of medical device maker  APYX.O  fall ~19% to $8
    ** FDA warns against use of co's Renuvion/J-Plasma device
for certain aesthetic procedures specifically those to improve
the appearance of skin  (https://bit.ly/3i71Qxv)
    ** Reports received describing serious adverse events when
device was used directly on skin and potentially
life-threatening adverse events when used under skin - FDA
    ** Agency says device has been cleared for general surgery
procedures not aesthetic skin procedures
    ** Stock down ~37.6% YTD, including session moves

 (Reporting by Mrinalika Roy in Bengaluru)
 ((mrinalika.roy@thomsonreuters.com; within U.S. +1 646 223
8780, outside U.S. +91 806749 8325;))